Ibrutinib 11014-0163-03
- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- November 7, 2013
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ibrutinib | 140 mg/1 |
Selected Package
11014-0163-03Selected1 BAG in 1 DRUM (11014-0163-3) / 113636 CAPSULE in 1 BAG